ECM1 and Leigh syndrome: The mouse skin sites injected either with a rabbit anti-ECM1 polyclonal antibody or an affinity-purified IgG from LS sera exhibited a clinicopathology compatible with the early clinical stage of LS, including erythematous swelling (dermal inflammation) and dilated blood vessels (telangiectasia) for up to two weeks after the initial injection.